Travere Therapeutics (TVTX)
(Delayed Data from NSDQ)
$6.82 USD
+0.07 (1.04%)
Updated May 8, 2024 04:00 PM ET
After-Market: $6.81 -0.01 (-0.15%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Travere Therapeutics, Inc. [TVTX]
Reports for Purchase
Showing records 121 - 126 ( 126 total )
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Glomerular Disorders 101: A Deep Dive Primer On Glomerular Dysfunction
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Looking For More Than Love In The Air In February - DUPLEX Data Feb 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
A Wrap On DUPLEX Enrollment; On To The Readout For Sparsentan and TVTX
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L